SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-294468
Filing Date
2023-12-13
Accepted
2023-12-13 17:22:30
Documents
14
Period of Report
2023-12-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d25647d8k.htm   iXBRL 8-K 24260
2 EX-99.1 d25647dex991.htm EX-99.1 64914
6 GRAPHIC g25647g48n93.jpg GRAPHIC 4001
  Complete submission text file 0001193125-23-294468.txt   231581

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crgx-20231213.xsd EX-101.SCH 2878
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crgx-20231213_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crgx-20231213_pre.xml EX-101.PRE 11726
8 EXTRACTED XBRL INSTANCE DOCUMENT d25647d8k_htm.xml XML 3478
Mailing Address 1900 ALAMEDA DE LAS PULGAS SUITE 350 SAN MATEO CA 94403
Business Address 1900 ALAMEDA DE LAS PULGAS SUITE 350 SAN MATEO CA 94403 650-379-6143
CARGO Therapeutics, Inc. (Filer) CIK: 0001966494 (see all company filings)

IRS No.: 844080422 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41859 | Film No.: 231484973
SIC: 2836 Biological Products, (No Diagnostic Substances)